Acute lung injury (ALI) from a variety of clinical disorders, characterized by diffuse
inflammation, is a cause of acute
respiratory failure that develops in patients of all ages. Previous studies reported that
wogonin, a
flavonoid-like chemical compound which was found in Scutellaria baicalensis, has anti-inflammatory effects in several
inflammation models, but not in ALI. Here, the in vivo protective effect of
wogonin in the amelioration of
lipopolysaccharide (LPS) -induced
lung injury and
inflammation was assessed. In addition, the in vitro effects and mechanisms of
wogonin were studied in the mouse macrophage cell lines Ana-1 and RAW264.7. In vivo results indicated that
wogonin attenuated LPS-induced histological alterations. Peripheral blood leucocytes decreased in the LPS-induced group, which was ameliorated by
wogonin. In addition,
wogonin inhibited the production of several inflammatory
cytokines, including tumour
necrosis factor-α, interleukin-1β (IL-1β) and
IL-6, in the bronchoalveolar lavage fluid and lung tissues after LPS challenge, while the
peroxisome proliferator-activated receptor γ (PPARγ) inhibitor
GW9662 reversed these effects. In vitro results indicated that
wogonin significantly decreased the secretion of
IL-6, IL-1β and tumour
necrosis factor-α in Ana-1 and RAW264.7 cells, which was suppressed by transfection of PPARγ
small interfering RNA and
GW9662 treatment. Moreover,
wogonin activated PPARγ, induced PPARγ-mediated attenuation of the nuclear translocation and the
DNA-binding activity of nuclear factor-κB in vivo and in vitro. In conclusion, all of these results showed that
wogonin may serve as a promising agent for the attenuation of ALI-associated
inflammation and pathology by regulating the PPARγ-involved nuclear factor-κB pathway.